80 related articles for article (PubMed ID: 17728268)
61. Primary and secondary prevention of cervical cancer--opportunities and challenges.
Markowitz LE; Unger ER; Saraiya M
J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
[No Abstract] [Full Text] [Related]
62. Human papillomavirus genotype distributions inform screening and vaccination policy.
Pinkowish MD
CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300
[No Abstract] [Full Text] [Related]
63. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
Brotherton JM
Vaccine; 2008 Jan; 26(2):250-6. PubMed ID: 18068276
[TBL] [Abstract][Full Text] [Related]
64. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US.
Saraiya M; Ahmed F; White M; Lawson H; Unger ER; Eheman C
Cancer; 2008 Nov; 113(10 Suppl):2837-40. PubMed ID: 18980202
[No Abstract] [Full Text] [Related]
65. Human papillomavirus vaccines: an update for gynecologists.
Ault KA
Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
[TBL] [Abstract][Full Text] [Related]
66. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
Zaratti L; Senatore S; Franco E
Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
[TBL] [Abstract][Full Text] [Related]
67. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
Knudtson M; Tiso S; Phillips S
Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
[TBL] [Abstract][Full Text] [Related]
68. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
Thomas TL
Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
[TBL] [Abstract][Full Text] [Related]
69. Human papillomavirus: HPV information for clinicians.
Centers for Disease Control and Prevention
Ala Nurse; 2008 Dec-2009 Feb; 35(4):17-9. PubMed ID: 19166076
[No Abstract] [Full Text] [Related]
70. Re: "Multiparameter calibration of a natural history model of cervical cancer".
Basu S; Galvani AP
Am J Epidemiol; 2007 Oct; 166(8):983; author reply 983-4. PubMed ID: 17728268
[No Abstract] [Full Text] [Related]
71. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point.
Giuliano AR; Salmon D
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):805-8. PubMed ID: 18398020
[No Abstract] [Full Text] [Related]
72. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
Bosch FX; Burchell AN; Schiffman M; Giuliano AR; de Sanjose S; Bruni L; Tortolero-Luna G; Kjaer SK; Muñoz N
Vaccine; 2008 Aug; 26 Suppl 10():K1-16. PubMed ID: 18847553
[TBL] [Abstract][Full Text] [Related]
73. Current acceptance of the HPV vaccine.
Miller MM; Wilson JM; Waldrop J
Nurse Pract; 2008 Apr; 33(4):18-22; quiz 22-3. PubMed ID: 18388548
[No Abstract] [Full Text] [Related]
74. Natural history and epidemiology of HPV infection and cervical cancer.
Castellsagué X
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
[TBL] [Abstract][Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]